摘要
目的:探讨雷贝拉唑联用莫沙比利治疗慢性胃炎的临床疗效。方法:收治慢性胃炎患者104例,随机分为研究组和对照组,每组各52例。对照组采用雷贝拉唑治疗,研究组采用雷贝拉唑联用莫沙比利治疗,比较两组临床疗效。结果:研究组治疗总有效率和幽门螺杆菌(Hp)根除率均明显优于对照组(P<0.05)。结论:雷贝拉唑联用莫沙比利治疗慢性胃炎的临床疗效显著。
Objective:To explore the clinical efficacy of rabeprazole combined with mosapride in the treatment of chronic gastritis.Methods:104 patients with chronic gastritis were selected,they were randomly divided into the study group and the control group.The control group was treated with rabeprazole,the study group was treated with rabeprazole combined with mosapride,we compared the clinical efficacy of the two groups.Results:In the study group,the total effective rate and the eradication rate of Helicobacter pylori(Hp)were significantly better than those in the control group(P<0.05).Conclusion:The clinical efficacy of rabeprazole combined with mosapride in the treatment of chronic gastritis was significant.
作者
姚静静
董军
Yao Jingjing;Dong Jun(Department of Gastroenterology,the People's Hospital of Rizhao City,Shandong 276800)
出处
《中国社区医师》
2018年第31期50-50,52,共2页
Chinese Community Doctors
